期刊文献+

骨性关节炎患者血液流变学的变化及丹参疗效观察 被引量:41

Changes of Hemorrheology and Effects of Salvia Miltiorrhiza Injection on Osteoarthritis
下载PDF
导出
摘要 目的探讨骨性关节炎(OA)患者血液流变学的变化及丹参注射液治疗效果。方法对15例OA患者的血液流变学指标进行了较全面的检测 ,并与正常人进行对照分析 ,同时观察丹参注射液治疗OA患者的临床效果及对血液流变学的影响。结果OA组较对照组的全血粘度 ,血浆粘度 ,红细胞压积 ,血小板粘附率 ,红细胞聚集指数 ,纤维蛋白原均明显增加 ;应用丹参注射液治疗OA患者 ,治疗后血液流变学指标明显得到改善 ,有显著性差异(P值分别<0.01 ,0.05) ,以临床治疗效果来看 ,丹参注射液治疗OA患者15例 ,显效5例 ,有效8例 ,无效2例 ,总有效率86.7 %。结论OA患者可伴随血液流变学异常 ,至血液呈高粘滞状态。丹参注射液治疗OA患者安全、有效、方便、价格低廉 ,值得临床推广应用。 Objective To explore the changes of hemorrheology and effects of salvia miltiorrhiza injection on osteoarthritis. Methods The hemorrheology indexes of 15 patiernts with osteoarthritis were determined and compared with controls. The effects of salvia miltiorrhiza injection on osteoarthritis were observed. Result The whole blood viscosity, the plasma viscosity, the hematocrit, the rate of aggregation of platelets, the index of erythrocyte aggregation, the fibrinogen were markedly increassed in osteoarthritis, as compared with those in controls. Patients with osteoarthritis treated by salvia miltiorrhiza injection, the hemorrheologic abnormality indexes were obviously improved, the difference was significant (P<0.01,0.05,respectively).In the treatment group, 5 cases were markedly effective, 8 effective and 2 ineffective, the total effective rate was 86.7%. Conclusion The hemorrheologic abnormalities and hypercoagulation state in osteoarthritis patients were observed. Salvia miltiorrhiza injection was safe,effective, convenient, and cheap in treating osteoarthritis patients, It has a good prospect of clinical application.
出处 《中国微循环》 2000年第1期48-49,共2页 Journal of Chinese Microcirculation
关键词 骨性关节炎 血液流变学 丹参注射液 治疗 Osteoarthritis Hemorrheology Salvia miltiorrhiza injection
  • 相关文献

参考文献6

二级参考文献55

  • 1Germán López-Larramona,Alfredo J Lucendo,Sonia González-Castillo,José M Tenias.Hepatic osteodystrophy: An important matter for consideration in chronic liver disease[J].World Journal of Hepatology,2011,3(12):300-307. 被引量:9
  • 2Ingolf Schiefke,Andreas Fach,Marcus Wiedmann,Andreas V.Aretin,Eva Schenker,Gudrun Borte,Manfred Wiese,Joachim Moessner.Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection[J].World Journal of Gastroenterology,2005,11(12):1843-1847. 被引量:24
  • 3王义国,刘倩,王文奇,陈自平,闫明先.乙型肝炎肝硬化骨代谢异常的临床研究[J].中华肝脏病杂志,2006,14(1):33-36. 被引量:9
  • 4Hay JE.Osteoporosis in liver diseases and after liver transplantation.J Hepatol 2003; 38:856-865.
  • 5Collier JD,Ninkovic M,Compston JE.Guidelines on the management of osteoporosis associated with chronic liver disease.Gut 2002; 50 Suppl 1:i1-i9.
  • 6Hay JE,Guichelaar MM.Evaluation and management of osteoporosis in liver disease.Clin Liver Dis 2005; 9:747-766,viii.
  • 7Sachdev S,Bhasin RC,Kumari CK,Reys M.A study of metabolic bone disorder in cirrhosis liver.J Assoc Physicians India 1976; 24:5-11.
  • 8Barger-Lux MJ,Heaney RP.Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption.J Clin Endocrinol Metab 2002; 87:4952-4956.
  • 9Nutrient requirements and recommended daily allowances for Indians:Report of the expert group of the Indian Council of Medical Research.National Institute of Nutrition,2000:41.
  • 10Leslie WD,Bernstein CN,Leboff MS.AGA technical review on osteoporosis in hepatic disorders.Gastroenterology 2003; 125:941-966.

共引文献1478

同被引文献354

引证文献41

二级引证文献322

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部